<DOC>
	<DOCNO>NCT02595762</DOCNO>
	<brief_summary>This disease registry prospective , multicenter non-interventional study design observe anti-cancer treatment regimens clinical outcome participant HER2-positive unresectable locally advanced breast cancer ( LABC ) metastatic breast cancer ( MBC ) .</brief_summary>
	<brief_title>A Study Treatment Patterns Outcomes Participants With Human Epidermal Growth Factor Receptor 2 ( HER2 ) -Positive Unresectable Locally Advanced Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Diagnosis HER2positive unresectable LABC MBC within 6 month prior enrollment None specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>